Seres Therapeutics
MCRB
MCRB
123 hedge funds and large institutions have $594M invested in Seres Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
0.06% less ownership
Funds ownership: 4.22% → 4.15% (-0.06%)
29% less call options, than puts
Call options by funds: $1.85M | Put options by funds: $2.62M
Holders
123
Holding in Top 10
2
Calls
$1.85M
Puts
$2.62M
Top Buyers
| 1 | +$7.34M | |
| 2 | +$4.54M | |
| 3 | +$3.12M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.99M |
| 5 |
Walleye Capital
New York
|
+$2.01M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$4.51M | |
| 3 | -$2.31M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.36M |
| 5 |
BlackRock
New York
|
-$1.19M |